Skip to Content

COVID-19 Transmission Low in Day Camps With Safety Measures

FRIDAY, Feb. 12, 2021 -- COVID-19 transmission can be mitigated in child care settings even during times of high community incidence, according to a study published Feb. 3 in Pediatrics.

Emily M. D'Agostino, D.P.H., from Duke University School of Medicine in Durham, North Carolina, and colleagues describe transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among >6,500 children (mean age, 8.5 years) and staff members (mean age, 22 years) at YMCA of the Triangle day camps in six North Carolina counties (March to August 2020). The camps reportedly adhered to multilayered safety strategies, including wearing face coverings during indoor and outdoor activities.

The researchers identified 19 primary symptomatic SARS-CoV-2 infections over the study period among 10 children (mean age, 9.7 years) and nine staff members (mean age, 27 years). These primary infections were linked to 3,030 contacts who were present in-person during the week prior to positive cases, but there were only two symptomatic secondary infections linked to primary cases. This yielded a SARS-CoV-2 primary case attack rate of 0.6 percent (19 of 3,030) and a secondary case transmission rate of 0.07 percent (two of 3,011).

"These findings suggest that the benefit of in-person programming in recreation settings with appropriate mitigation may outweigh the risk of viral transmission," the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Response to One Dose of COVID-19 Vaccine Strong for Previously Infected

TUESDAY, March 2, 2021 -- Individuals with previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection generate strong responses to one dose of the BNT162b2...

Only Two in 10 Older Adults Report Being Screened for Hearing Loss

TUESDAY, March 2, 2021 -- Eight in 10 older adults say they have not been screened for hearing loss in primary care within the last two years, according to a report published...

​IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19​

TUESDAY, March 2, 2021 -- Treatment with interleukin-6 receptor antagonists tocilizumab and sarilumab improves outcomes among critically ill patients with COVID-19 receiving organ...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.